Sinopharm Group Co (HK:1099) has released an update.
Sinopharm Group Co. Ltd. has scheduled a board meeting for October 25, 2024, to review and approve its unaudited quarterly financial results for the nine months ending September 30, 2024. This notice underscores the company’s commitment to transparency and compliance with regulatory standards. Shareholders and investors are likely to keep a close watch for insights into the company’s performance and strategic direction.
For further insights into HK:1099 stock, check out TipRanks’ Stock Analysis page.
